Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDMN
4551
DELISTED
Kadmon Holdings, Inc.
KDMN
| $215K | ﹤0.01% |
+59,500
| New | +$212K |
|
|
OSG
4552
Octave Specialty Group
OSG
$257M
| $214K | ﹤0.01% |
13,429
-21,828
| -62% | -$336K |
|
4553
Casella Waste Systems
CWST
$5.72B
| $214K | ﹤0.01% |
9,324
-3,223
| -26% | -$63.4K |
|
4554
PUT
ProShares UltraShort Euro
EUO
$34.7M
| $214K | ﹤0.01% |
10,100
+1,700
| +20% | +$37.2K |
|
4555
SPX Corp
SPXC
$11B
| $214K | ﹤0.01% |
6,821
+5,065
| +288% | +$154K |
|
4556
CALL
Zumiez
ZUMZ
$333M
| $214K | ﹤0.01% |
10,300
+8,600
| +506% | +$165K |
|
|
HTLF
4557
DELISTED
Heartland Financial USA, Inc.
HTLF
| $214K | ﹤0.01% |
3,997
+3,427
| +601% | +$173K |
|
|
REV
4558
CALL
DELISTED
Revlon, Inc.
REV
| $214K | ﹤0.01% |
9,800
-42,300
| -81% | -$937K |
|
4559
Knowles
KN
$3.44B
| $213K | ﹤0.01% |
14,508
+6,596
| +83% | +$103K |
|
4560
CALL
MiMedx Group
MDXG
$596M
| $213K | ﹤0.01% |
16,900
+8,500
| +101% | +$104K |
|
4561
CALL
OneSpan
OSPN
$598M
| $213K | ﹤0.01% |
15,300
+13,500
| +750% | +$178K |
|
4562
Riot Platforms
RIOT
$8.38B
| $213K | ﹤0.01% |
+7,500
| New | +$105K |
|
4563
Gibraltar Industries
ROCK
$1.58B
| $213K | ﹤0.01% |
6,450
+1,486
| +30% | +$47.5K |
|
|
BDSI
4564
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $213K | ﹤0.01% |
72,386
+72,329
| +126,893% | +$200K |
|
4565
Matsons
MATX
$6.12B
| $212K | ﹤0.01% |
7,095
+1,532
| +28% | +$43.3K |
|
4566
MACOM Technology Solutions
MTSI
$22.3B
| $212K | ﹤0.01% |
6,525
-10,157
| -61% | -$367K |
|
|
RDUS
4567
DELISTED
Radius Recycling
RDUS
| $212K | ﹤0.01% |
6,314
+4,366
| +224% | +$128K |
|
4568
Universal Electronics
UEIC
$60.6M
| $212K | ﹤0.01% |
4,488
+3,795
| +548% | +$210K |
|
4569
Weis Markets
WMK
$1.87B
| $212K | ﹤0.01% |
5,124
+3,524
| +220% | +$142K |
|
|
TRHC
4570
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $212K | ﹤0.01% |
7,552
+7,335
| +3,380% | +$215K |
|
4571
iShares US Technology ETF
IYW
$24.9B
| $211K | ﹤0.01% |
+5,196
| New | +$208K |
|
|
ODP
4572
PUT
DELISTED
ODP
ODP
| $211K | ﹤0.01% |
5,970
-6,190
| -51% | -$214K |
|
4573
US Foods
USFD
$23.5B
| $211K | ﹤0.01% |
6,585
-109,681
| -94% | -$3.11M |
|
|
EQC
4574
CALL
DELISTED
Equity Commonwealth
EQC
| $211K | ﹤0.01% |
+6,900
| New | +$209K |
|
|
NXEO
4575
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
| $211K | ﹤0.01% |
23,167
+22,557
| +3,698% | +$178K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.